Prescribing statin drugs to patients with heart failure can lower their risk of both developing and dying from cancer, according to a new study, which assessed results over a four-year follow-up period.
The research – published today in the European Heart Journal – found that compared with non-statin users, those taking the medicines had a 16 per cent less chance of getting cancer. Meanwhile, a statin user’s likelihood of dying from cancer was reduced by 26 per cent.
